| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |